Transaction · 0002009762-26-000005
HRMYHarmony Biosciences Holdings, Inc.
Budur Kumar
Budur Kumar, CMO, reported an open-market or private sale at Harmony Biosciences Holdings, Inc. involving 5500.000000 shares for an estimated $230911.45. Reported holdings after the transaction were 18615.000000 shares. The stored filing text includes a detected 10b5-1 reference.
Open-market sellSEC transaction code SCMO
- Trade date
- Sep 04, 2026
- Filing date
- Sep 09, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 24,115 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
HRMY price since this filing
Daily closing prices, with the filing date and available return windowsHRMY · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0002009762-26-000005 Common Stock
- Transaction date
- Sep 04, 2026 Filed Sep 09, 2026, 09:12 PM · 5d delay
- Shares
- 5,500 sh $41.98 per share
- Estimated value
- -$230k Computed from shares × price
- Holdings after
- 18,615 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Reduction 10b5-1 Detected
Filing-only score
-4 points
Compact filing score computed from stored Form 4 facts. Version v1.
Neutral filing signal
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
CHIEF MEDICAL OFFICER
Officer YesDirector No10% NoOther No
Footnotes & amended
- F1
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.51 to $42.32. The reporting person undertakes to provide to the I…
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.59 to $42.57. The reporting person undertakes to provide to the I…
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.59 to $43.02. The reporting person undertakes to provide to the I…
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.20. The reporting person undertakes to provide to the I…
- F6
The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the g…
- F7
The stock option vests with respect to 25% of the underlying shares on May 1, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant…
Related transactions
Same SEC filing0 other transactions
Recent company activity
HRMY0 recent txs